Overview
Royal DSM
Koninklijke DSM (DSM), part of dsm-firmenich, is a global leader in health and nutrition, utilizing bioscience to enhance the well-being of people, animals, and the planet. They manufacture nutritional products and performance materials. In human nutrition, DSM provides tailored, high-quality solutions to promote people's well-being at every stage of life, including nutritional ingredients, consumer-branded products, and personalized nutrition. In
...
Read More animal nutrition and health, DSM develops essential vitamins, premix solutions, and specialty feed additive solutions, including mycotoxin risk management solutions and diagnostics, to facilitate a sustainable transformation in global food production. The company derives the majority of its revenue from outside the Netherlands. DSM recently merged with Firmenich International SA in mid-2023, forming dsm-firmenich AG, a leader in nutrition, health, and beauty.
Read Less
Read More animal nutrition and health, DSM develops essential vitamins, premix solutions, and specialty feed additive solutions, including mycotoxin risk management solutions and diagnostics, to facilitate a sustainable transformation in global food production. The company derives the majority of its revenue from outside the Netherlands. DSM recently merged with Firmenich International SA in mid-2023, forming dsm-firmenich AG, a leader in nutrition, health, and beauty.
Read Less
Joris Franciscus Maria Angela de Beer
See more contacts
Management of Companies and Enterprises
,
Scientific Research and Development Services
,
Holding companies, nec
,
Engineering laboratory, except testing
?
?
?
Actual
?
Actual
#
Actual
? %
? %
?
?
?
?
Contacts
Get in Touch with 14 Principals*
-
Joris Franciscus Maria Angela de BeerDirector
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of ? (12 month period) in USD
Annual Revenue 2023
?
USD
Actual
1 USD = 0.9456 EUR
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Net Operating Cash | $609 | $1,020 | $1,509 |
| Net Investing Cash | $2,867 | $926 | $220 |
| Net Financing Cash | -$4,074 | -$682 | -$1,041 |
| Net Change in Cash | -$597 | $1,265 | $688 |
| Cash at Beginning of Period | $2,913 | $1,651 | $921 |
| Cash at End of Period | $2,306 | $2,913 | $1,651 |
| Capital Expenditure | -$582 | -$688 | -$610 |
| Assets (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $2,306 | $2,913 | $1,651 |
| Accounts Receivable | $1,623 | $1,595 | $1,696 |
| Inventories | $2,451 | $2,474 | $2,429 |
| Other Current Assets | $536 | $1,614 | $706 |
| Asset Summary | |||
| Total Current Assets | $6,917 | $8,595 | $6,483 |
| Tangible Fixed Assets | $3,693 | $3,782 | $4,192 |
| Intangible Assets | $2,295 | $2,287 | $2,518 |
| Total Assets | $15,742 | $17,403 | $16,020 |
| Liabilities (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $1,442 | $1,496 | $1,661 |
| Short-Term Debt | $617 | $44 | $57 |
| Other Current Liabilities | $1,514 | $1,164 | $851 |
| Liability Summary | |||
| Total Current Liabilities | $3,573 | $2,705 | $2,570 |
| Long-Term Debt | $2,427 | $3,006 | $ |
| Other Long-Term Liabilities | $80 | $159 | $231 |
| Total Liabilities | $7,211 | $6,935 | $7,004 |
| Stakeholder's Equity (mil) | 2023 | 2022 | 2021 |
|---|---|---|---|
| Equity | |||
| Common Stock | $276 | $347 | $347 |
| Retained Earnings | $8,285 | $10,339 | $9,031 |
| Equity Summary | |||
| Total Equity | $9,321 | $11,361 | $9,854 |
| Shares Outstanding | 174,018,034 | 173,075,397 | 172,968,730 |